ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BGPP8L80
Stock Name / FundiShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerWMVG(GBP) LSE
ETF TickerWMVG.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-15 (Monday)5,049USD 3,799,978REGN holding increased by 57205USD 3,799,9780USD 57,205 USD 752.62 USD 741.29
2025-12-12 (Friday)5,049USD 3,742,773REGN holding decreased by -27820USD 3,742,7730USD -27,820 USD 741.29 USD 746.8
2025-12-11 (Thursday)5,049USD 3,770,593REGN holding increased by 103959USD 3,770,5930USD 103,959 USD 746.8 USD 726.21
2025-12-10 (Wednesday)5,049USD 3,666,634REGN holding increased by 169798USD 3,666,6340USD 169,798 USD 726.21 USD 692.58
2025-12-09 (Tuesday)5,049USD 3,496,836REGN holding decreased by -53924USD 3,496,8360USD -53,924 USD 692.58 USD 703.26
2025-12-08 (Monday)5,049REGN holding increased by 44USD 3,550,760REGN holding decreased by -44632USD 3,550,76044USD -44,632 USD 703.26 USD 718.36
2025-12-05 (Friday)5,005USD 3,595,392REGN holding decreased by -22222USD 3,595,3920USD -22,222 USD 718.36 USD 722.8
2025-12-04 (Thursday)5,005USD 3,617,614REGN holding decreased by -4354USD 3,617,6140USD -4,354 USD 722.8 USD 723.67
2025-12-03 (Wednesday)5,005USD 3,621,968REGN holding decreased by -91742USD 3,621,9680USD -91,742 USD 723.67 USD 742
2025-12-02 (Tuesday)5,005USD 3,713,710REGN holding decreased by -40591USD 3,713,7100USD -40,591 USD 742 USD 750.11
2025-12-01 (Monday)5,005USD 3,754,301REGN holding decreased by -150550USD 3,754,3010USD -150,550 USD 750.11 USD 780.19
2025-11-28 (Friday)5,005USD 3,904,851REGN holding decreased by -22122USD 3,904,8510USD -22,122 USD 780.19 USD 784.61
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BGPP8L80

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-08BUY44724.130701.745 703.983USD 30,975 657.95
2025-11-25BUY176790.570760.700 763.687USD 134,409 654.17
2025-11-24SELL-6,982773.130756.640 758.289USD -5,294,374 653.70 Loss of -730,218 on sale
2025-11-20BUY55 737.000* 652.89
2025-11-17BUY53711.880692.290 694.249USD 36,795 652.12
2025-11-14SELL-106699.270686.000 687.327USD -72,857 651.93 Loss of -3,752 on sale
2025-11-04SELL-112646.221625.140 627.248USD -70,252 651.62 Profit of 2,730 on sale
2025-10-31BUY53659.760645.000 646.476USD 34,263 651.67
2025-10-28SELL-108654.480655.700 655.578USD -70,802 651.63 Loss of -426 on sale
2025-10-21SELL-106579.340582.410 582.103USD -61,703 653.36 Profit of 7,553 on sale
2025-10-14SELL-53572.600576.180 575.822USD -30,519 655.32 Profit of 4,213 on sale
2025-10-02SELL-217600.000605.410 604.869USD -131,257 656.23 Profit of 11,145 on sale
2025-09-25SELL-53555.510579.000 576.651USD -30,563 658.50 Profit of 4,338 on sale
2025-09-16BUY48575.060579.400 578.966USD 27,790 659.64
2025-09-12SELL-212560.000570.000 569.000USD -120,628 660.63 Profit of 19,426 on sale
2025-09-09SELL-116556.530563.570 562.866USD -65,292 662.26 Profit of 11,530 on sale
2025-07-28SELL-88558.630567.950 567.018USD -49,898 668.66 Profit of 8,945 on sale
2025-07-15SELL-328547.960574.750 572.071USD -187,639 672.18 Profit of 32,837 on sale
2025-07-11SELL-164567.740568.460 568.388USD -93,216 673.42 Profit of 17,226 on sale
2025-07-02BUY82547.740551.500 551.124USD 45,192 678.92
2025-06-30SELL-246525.000526.080 525.972USD -129,389 679.89 Profit of 37,864 on sale
2025-06-27SELL-264521.000531.210 530.189USD -139,970 680.90 Profit of 39,789 on sale
2025-06-26BUY82521.000524.520 524.168USD 42,982 681.93
2025-06-25SELL-82520.290525.630 525.096USD -43,058 682.97 Profit of 12,946 on sale
2025-06-23SELL-249511.920516.180 515.754USD -128,423 685.14 Profit of 42,177 on sale
2025-06-20SELL-83509.720521.310 520.151USD -43,173 686.29 Profit of 13,790 on sale
2025-06-16SELL-832522.680538.200 536.648USD -446,491 690.93 Profit of 128,365 on sale
2025-06-13SELL-82529.240529.550 529.519USD -43,421 692.03 Profit of 13,326 on sale
2025-06-12SELL-164521.840525.220 524.882USD -86,081 693.20 Profit of 27,604 on sale
2025-06-11SELL-410518.600528.370 527.393USD -216,231 694.40 Profit of 68,474 on sale
2025-06-09SELL-82517.600518.270 518.203USD -42,493 696.83 Profit of 14,648 on sale
2025-05-30SELL-81490.280519.780 516.830USD -41,863 705.96 Profit of 15,320 on sale
2025-05-28SELL-81591.850606.000 604.585USD -48,971 707.55 Profit of 8,340 on sale
2025-05-21SELL-81604.620617.520 616.230USD -49,915 711.83 Profit of 7,744 on sale
2025-05-14SELL-1,105571.360580.560 579.640USD -640,502 716.61 Profit of 151,353 on sale
2025-05-09BUY421527.780552.840 550.334USD 231,691 720.48
2025-05-07SELL-324560.930568.130 567.410USD -183,841 723.25 Profit of 50,493 on sale
2025-05-01BUY81590.000593.930 593.537USD 48,076 727.87
2025-04-29SELL-902568.910579.980 578.873USD -522,143 730.39 Profit of 136,671 on sale
2025-04-28SELL-82610.860614.830 614.433USD -50,384 731.45 Profit of 9,595 on sale
2025-04-25BUY82602.640602.790 602.775USD 49,428 732.60
2025-04-23BUY847587.850603.770 602.178USD 510,045 735.12
2025-04-22BUY720585.490587.100 586.939USD 422,596 736.50
2025-04-15SELL-240557.910575.200 573.471USD -137,633 743.28 Profit of 40,755 on sale
2025-04-14BUY416571.060574.720 574.354USD 238,931 744.94
2025-04-11BUY406554.180555.530 555.395USD 225,490 746.79
2025-04-09SELL-240576.720580.730 580.329USD -139,279 750.46 Profit of 40,831 on sale
2025-04-08SELL-320556.810586.030 583.108USD -186,595 752.40 Profit of 54,172 on sale
2025-04-07SELL-80572.780591.540 589.664USD -47,173 754.21 Profit of 13,164 on sale
2025-04-04BUY80573.450612.990 609.036USD 48,723 756.05
2025-04-01BUY320617.000641.240 638.816USD 204,421 758.86
2025-03-27SELL-160635.830643.430 642.670USD -102,827 762.83 Profit of 19,226 on sale
2025-03-21SELL-80658.480661.000 660.748USD -52,860 767.97 Profit of 8,578 on sale
2025-03-14BUY240666.870686.980 684.969USD 164,393 773.86
2025-03-13BUY80680.610698.950 697.116USD 55,769 774.98
2025-03-12BUY160689.500712.460 710.164USD 113,626 776.03
2025-03-11BUY160718.160747.700 744.746USD 119,159 776.74
2025-03-10SELL-80744.830748.290 747.944USD -59,836 777.14 Profit of 2,336 on sale
2025-03-07BUY1,343707.510729.750 727.526USD 977,067 778.02
2025-03-05BUY400687.150692.790 692.226USD 276,890 779.19
2025-03-04BUY160675.490697.460 695.263USD 111,242 780.53
2025-03-03BUY320684.870704.640 702.663USD 224,852 781.79
2025-02-27BUY80702.780721.000 719.178USD 57,534 783.98
2025-02-26BUY640706.940721.410 719.963USD 460,776 785.04
2025-02-25BUY160723.470739.000 737.447USD 117,992 785.89
2025-02-20BUY240696.020703.140 702.428USD 168,583 789.49
2025-02-05BUY80716.720729.250 727.997USD 58,240 808.95
2025-02-04BUY80697.050709.980 708.687USD 56,695 810.91
2025-01-31SELL-80672.980688.000 686.498USD -54,920 816.04 Profit of 10,363 on sale
2025-01-30BUY80683.080689.620 688.966USD 55,117 818.50
2025-01-29SELL-80687.270697.570 696.540USD -55,723 820.98 Profit of 9,955 on sale
2025-01-28BUY160686.330690.300 689.903USD 110,384 823.57
2025-01-27SELL-80684.710698.450 697.076USD -55,766 826.29 Profit of 10,337 on sale
2024-12-10SELL-80778.500791.490 790.191USD -63,215 833.16 Profit of 3,438 on sale
2024-12-03SELL-160749.570770.000 767.957USD -122,873 840.79 Profit of 11,654 on sale
2024-11-29SELL-80750.220754.510 754.081USD -60,326 844.92 Profit of 7,267 on sale
2024-11-25SELL-502749.510757.860 757.025USD -380,027 860.76 Profit of 52,077 on sale
2024-11-25SELL-502749.510757.860 757.025USD -380,027 860.76 Profit of 52,077 on sale
2024-11-22SELL-246738.000751.400 750.060USD -184,515 864.37 Profit of 28,121 on sale
2024-11-05SELL-656829.430836.630 835.910USD -548,357 907.48 Profit of 46,951 on sale
2024-11-05SELL-656829.430836.630 835.910USD -548,357 907.48 Profit of 46,951 on sale
2024-10-29BUY82927.330932.380 931.875USD 76,414 942.81
2024-10-29BUY82927.330932.380 931.875USD 76,414 942.81
2024-10-24BUY82928.900952.020 949.708USD 77,876 955.19
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy